Alemtuzumab treatment for hemophagocytic lymphohistiocytosis

Nature Reviews Clinical Oncology

Volumn 7, Issue 10, 2010, Pages

  MacHaczka, MacIej ^a   Vaktnäs, Johan ^b   Chiang, Samuel C C ^a   Bryceson, Yenan T ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b VARBERG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; MONOCLONAL ANTIBODY;

CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFICACY; DRUG WITHDRAWAL; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; LEUKEMIA RELAPSE; MILIARY TUBERCULOSIS; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTIC LEUKEMIA; PROMYELOCYTIC LEUKEMIA; SPLENECTOMY; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; MIDDLE AGED; NOTE; STEM CELL TRANSPLANTATION;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION;

EID: 77957597585     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2010.40-c1     Document Type: Letter

References (7)

1. Strout, M. P., Seropian, S. & Berliner, N. Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis. Nat. Rev. Clin. Oncol. 7, 415-420 (2010).
2. Motta, M., Wierda, W. G. & Ferrajoli, A. Chronic lymphocytic leukemia: treatment options for patients with refractory disease. Cancer 115, 3830-3841 (2009).
3. Bauer, M. P., Burgel, N. D., Marijt, W. A., van Dissel, J. T. & von dem Borne, P. A. Fever, shock and pancytopenia in a patient treated with alemtuzumab. Clin. Inf. Dis. 49, 1540;1616-1617 (2009).
4. Henter, J. I. et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48, 124-131 (2007).
5. Janka, G. Hemophagocytic lymphohistiocytosis: When the immune system runs amok. Klin. Padiatr. 221, 278-285 (2009).
6. Ishii, E. et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int. J. Hematol. 86, 58-65 (2007).
7. Lackner, H. et al. Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica 93, 291-294 (2008).